Hakenberg P, Kalev G, Seyfried S, Reißfelder C, Hardt J
Department of Surgery, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany.
Medical Faculty Mannheim, DKFZ-Hector Cancer Institute, Heidelberg University, Mannheim, Germany.
Langenbecks Arch Surg. 2025 Apr 2;410(1):116. doi: 10.1007/s00423-025-03692-x.
Treatment of locally recurrent rectal cancer (LRRC) is still challenging because of inhomogeneous patient cohorts regarding previous treatments as well as different recurrence patterns and locations. The aim of this study was to investigate the treatments and surgical approaches tailored to them.
We included all patients who were treated for LRRC without distant metastasis at the University Medical Center Mannheim, Germany, between 2010 and 2021. We collected data from our electronic clinical data management system regarding the initial diagnosis and treatment, as well as the locations and treatment of the recurrent tumor.
We identified a total of 666 patients who were curatively treated for rectal cancer of whom 36 patients (5.4%) developed LRRC without distant recurrence. Most patients (26/36) had a tailored therapy regimen that included surgery with or without perioperative radiation and/or chemotherapy. The most common site of local relapse was around the former colorectal anastomosis (15/36, 41.7%). The operative procedures ranged from anterior resection to multi-organ resection and exenteration. A complete resection (R0) could be achieved in twelve patients (12/22. 54.5%). The 3- and 5-year overall survival rates were 79% and 72%, respectively.
Most local recurrences occur at the anastomotic site and are mostly eligible for curative surgical therapy with good long-term survival.
局部复发性直肠癌(LRRC)的治疗仍然具有挑战性,这是因为患者群体在既往治疗、复发模式及部位方面存在不均一性。本研究的目的是探讨针对其的治疗方法和手术方式。
我们纳入了2010年至2021年间在德国曼海姆大学医学中心接受LRRC治疗且无远处转移的所有患者。我们从电子临床数据管理系统收集了有关初始诊断和治疗以及复发性肿瘤的部位和治疗的数据。
我们共确定了666例接受直肠癌根治性治疗的患者,其中36例(5.4%)发生LRRC且无远处复发。大多数患者(26/36)采用了量身定制的治疗方案,包括手术联合或不联合围手术期放疗和/或化疗。局部复发最常见的部位是原结直肠吻合口周围(15/36,41.7%)。手术方式从前部切除术到多器官切除术及盆腔廓清术不等。12例患者(12/22,54.5%)实现了根治性切除(R0)。3年和5年总生存率分别为79%和72%。
大多数局部复发发生在吻合口部位,大多适合接受根治性手术治疗,长期生存良好。